Apr 15,2021 11:30 AM
Biocon was the top underperformer of the day tumbling by 1.13% at Rs402.35 per piece dragging the index.
|Resolution Type||Description Of Resolution||IiAS Recommendation|
|Name||LTP||PE||Mar Cap||NP Qtr||Div. Yld||Sales Qtr||BV|
|Sun Pharmaceuticals Industries Ltd||645.15||52.15||154,769.10||555.55||0.62||3,366.01||106.10|
|Divis Laboratories Ltd||3,779.70||54.05||100,448.00||461.24||0.42||1,656.48||313.47|
|Dr Reddys Laboratories Ltd||5,156.75||36.05||85,710.93||443.70||0.48||3,397.50||979.36|
|Aurobindo Pharma Ltd||987.30||19.40||57,855.58||740.51||0.30||3,701.14||246.88|
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Torrent Pharmaceuticals is one of the leading pharmaceutical companies having presence in Indian and global markets. The company is a dominant player in the therapeutic areas of cardiovascular (CV) and central nervous system (CNS). The company also has significant presence in Gastro-Intestinal, Diabetology, Anti-Infective and Pain Management segments. The company has a modern and well-equipped state-of-the-art R&D Centre at Bhat near A... More
Reports by torrent-pharmaceuticals-ltd-share-price
Apr 21, 2021 01:23 PM
The company’s consolidated revenue stood at Rs1,988cr, up 34.6% yoy and 4.96% qoq.
08 Feb 2021
15 Feb 2021
We would like to inform that the Board has at its meeting held today approved an interim dividend of... More
08 Feb 2021
18 Jan 2021
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Compa... More